oxybutynin has been researched along with Smoking Cessation in 30 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Smoking Cessation: Discontinuing the habit of SMOKING.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A cost-effectiveness analysis was undertaken alongside the smoking, nicotine, and pregnancy trial to compare NRT patches plus behavioral support to behavioral support alone, for pregnant women who smoked." | 9.20 | Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). ( Coleman, T; Cooper, S; Essex, HN; Li, J; Parrott, S; Wu, Q, 2015) |
| "The authors conducted a randomized, placebo-controlled study of nicotine replacement therapy for the reduction of agitation and aggression in smokers with schizophrenia." | 9.15 | Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. ( Adam, E; Allen, MH; Damsa, C; Debanné, M; Dickinson, LM; Lazignac, C, 2011) |
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 6.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| "A large proportion of vascular patients who received 2 weeks of nicotine replacement with or without the addition of brief smoking cessation counseling delivered by a vascular surgery provider were able to reduce smoking and maintain reduction after 6 months." | 5.30 | A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease. ( Holder, T; Indes, JE; Muhs, B; Ochoa Chaar, CI; Rajaee, S; Sarac, T; Sumpio, B; Toll, BA, 2019) |
| "A cost-effectiveness analysis was undertaken alongside the smoking, nicotine, and pregnancy trial to compare NRT patches plus behavioral support to behavioral support alone, for pregnant women who smoked." | 5.20 | Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP). ( Coleman, T; Cooper, S; Essex, HN; Li, J; Parrott, S; Wu, Q, 2015) |
| "We previously reported short-term results from a perioperative randomized controlled trial comparing usual care with an intervention involving (1) brief counseling by the preadmission nurse, (2) smoking cessation brochures, (3) referral to a telephone quitline, and (4) a free 6-week supply of transdermal nicotine replacement." | 5.20 | Long-term quit rates after a perioperative smoking cessation randomized controlled trial. ( Buhrmann, O; Jones, PM; Landry, J; Lee, SM; Morley-Forster, P, 2015) |
| "Participants (N = 365) in a larger smoking cessation clinical trial completed the modified Simon task twice (while 10-h nicotine-deprived vs." | 5.15 | Cognitive conflict following appetitive versus negative cues and smoking cessation failure. ( Baker, TB; Curtin, JJ; Gloria, R; Japuntich, SJ; Piper, ME; Schlam, TR, 2011) |
| "The authors conducted a randomized, placebo-controlled study of nicotine replacement therapy for the reduction of agitation and aggression in smokers with schizophrenia." | 5.15 | Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study. ( Adam, E; Allen, MH; Damsa, C; Debanné, M; Dickinson, LM; Lazignac, C, 2011) |
| "Using baseline data from a randomized clinical trial to examine the efficacy of selegiline for cigarette smoking cessation (n = 280), we conducted univariate analyses (analysis of variance or chi-square) to determine statistically significant predictors of a successful quit attempt (SQA) versus unsuccessful quit attempt." | 5.15 | Predicting successful 24-hr quit attempt in a smoking cessation intervention. ( Bailey, SR; Bryson, SW; Killen, JD, 2011) |
| "Randomised controlled trials and meta-analyses have demonstrated that single therapy with either NRT, bupropion or varenicline are all more effective than placebo for smoking cessation." | 4.86 | Smoking cessation-recent advances. ( Ioannides-Demos, LL; McNeil, JJ; Piccenna, L, 2010) |
| "Fixed-dose nicotine replacement therapy (NRT) is efficacious for smoking cessation in the general population of smokers." | 3.79 | Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving. ( Andriash, K; Busto, UE; Persad, D; Selby, P; Zack, M; Zawertailo, L, 2013) |
| "Nicotine dependence was assessed by the Fagerström Test for Nicotine Dependence (FTND) questionnaire, withdrawal symptoms by the Minnesota Nicotine Withdrawal Scale questionnaire and smoking cessation by self-reported abstinence at 1 week, 1 month and 6 months after treatment." | 2.75 | Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients. ( Beels, L; De Ruyck, K; De Volder, A; Meysman, M; Nackaerts, K; Salhi, B; Thierens, H; Van Meerbeeck, J; Werbrouck, J, 2010) |
| "The data about smoking cessation are limited; there has not yet been a study primarily focused on changes in steroids levels." | 1.39 | Effects of smoking cessation on hormonal levels in men. ( Dušková, M; Hill, M; Hruškovičová, H; Králíková, E; Pospíšilová, H; Rácz, B; Simůnková, K; Stárka, L; Vondra, K, 2013) |
| "The nicotine patch was the most commonly used form of NRT." | 1.37 | Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers. ( Aveyard, P; Beard, E; Fidler, J; McNeill, A; Michie, S; West, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 30 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rajaee, S | 1 |
| Holder, T | 1 |
| Indes, JE | 1 |
| Muhs, B | 1 |
| Sarac, T | 1 |
| Sumpio, B | 1 |
| Toll, BA | 2 |
| Ochoa Chaar, CI | 1 |
| Bernstein, SL | 2 |
| Dziura, J | 1 |
| Weiss, J | 1 |
| Miller, T | 1 |
| Vickerman, KA | 1 |
| Grau, LE | 1 |
| Pantalon, MV | 1 |
| Abroms, L | 1 |
| Collins, LM | 1 |
| Toll, B | 1 |
| Baldassarri, SR | 1 |
| Chupp, GL | 1 |
| Slade, MD | 1 |
| Fucito, LM | 1 |
| Selby, P | 1 |
| Andriash, K | 1 |
| Zawertailo, L | 1 |
| Persad, D | 1 |
| Zack, M | 1 |
| Busto, UE | 1 |
| Pollak, KI | 1 |
| Lyna, P | 1 |
| Bilheimer, AK | 1 |
| Gordon, KC | 1 |
| Peterson, BL | 1 |
| Gao, X | 1 |
| Swamy, GK | 1 |
| Denman, S | 1 |
| Gonzalez, A | 1 |
| Rocha, P | 1 |
| Fish, LJ | 1 |
| Burns, EK | 1 |
| Hood, NE | 1 |
| Goforth, E | 1 |
| Levinson, AH | 1 |
| Essex, HN | 1 |
| Parrott, S | 1 |
| Wu, Q | 1 |
| Li, J | 1 |
| Cooper, S | 1 |
| Coleman, T | 1 |
| Lee, SM | 1 |
| Landry, J | 1 |
| Jones, PM | 1 |
| Buhrmann, O | 1 |
| Morley-Forster, P | 1 |
| Saladin, ME | 1 |
| McClure, EA | 1 |
| Baker, NL | 1 |
| Carpenter, MJ | 1 |
| Ramakrishnan, V | 1 |
| Hartwell, KJ | 1 |
| Gray, KM | 1 |
| Prochaska, JJ | 1 |
| Fromont, SC | 1 |
| Ramo, DE | 1 |
| Young-Wolff, KC | 1 |
| Delucchi, K | 1 |
| Brown, RA | 1 |
| Hall, SM | 1 |
| Yingst, JM | 1 |
| Veldheer, S | 1 |
| Hrabovsky, S | 1 |
| Sciamanna, C | 1 |
| Foulds, J | 1 |
| Liachenko, N | 1 |
| Boulamery, A | 1 |
| Simon, N | 1 |
| Ciancio, G | 1 |
| Colina, M | 1 |
| La Corte, R | 1 |
| Lo Monaco, A | 1 |
| De Leonardis, F | 1 |
| Trotta, F | 1 |
| Govoni, M | 1 |
| Escobar-Chávez, JJ | 1 |
| Merino, V | 1 |
| Díez-Sales, O | 1 |
| Nácher-Alonso, A | 1 |
| Ganem-Quintanar, A | 1 |
| Herráez, M | 1 |
| Merino-Sanjuán, M | 1 |
| Cummings, KM | 1 |
| Fix, BV | 1 |
| Celestino, P | 1 |
| Hyland, A | 1 |
| Mahoney, M | 1 |
| Ossip, DJ | 1 |
| Bauer, U | 1 |
| McNeil, JJ | 1 |
| Piccenna, L | 1 |
| Ioannides-Demos, LL | 1 |
| De Ruyck, K | 1 |
| Nackaerts, K | 1 |
| Beels, L | 1 |
| Werbrouck, J | 1 |
| De Volder, A | 1 |
| Meysman, M | 1 |
| Salhi, B | 1 |
| Van Meerbeeck, J | 1 |
| Thierens, H | 1 |
| Lycett, D | 1 |
| Munafò, M | 1 |
| Johnstone, E | 1 |
| Murphy, M | 1 |
| Aveyard, P | 2 |
| Schlam, TR | 1 |
| Japuntich, SJ | 1 |
| Piper, ME | 1 |
| Gloria, R | 1 |
| Baker, TB | 1 |
| Curtin, JJ | 1 |
| Beard, E | 1 |
| McNeill, A | 1 |
| Fidler, J | 1 |
| Michie, S | 1 |
| West, R | 1 |
| Berlin, I | 1 |
| Jacob, N | 1 |
| Coudert, M | 1 |
| Perriot, J | 1 |
| Schultz, L | 1 |
| Rodon, N | 1 |
| Allen, MH | 1 |
| Debanné, M | 1 |
| Lazignac, C | 1 |
| Adam, E | 1 |
| Dickinson, LM | 1 |
| Damsa, C | 1 |
| Inoue, K | 1 |
| Takeshima, F | 1 |
| Kadota, K | 1 |
| Yoda, A | 1 |
| Tatsuta, Y | 1 |
| Nagaura, Y | 1 |
| Yoshioka, S | 1 |
| Nakamichi, S | 1 |
| Nakao, K | 1 |
| Ozono, Y | 1 |
| Simon, JA | 1 |
| Javitz, HS | 1 |
| Swan, GE | 1 |
| Lerman, C | 1 |
| Cabezas, C | 1 |
| Advani, M | 1 |
| Puente, D | 1 |
| Rodriguez-Blanco, T | 1 |
| Martin, C | 1 |
| Clark, SM | 1 |
| Nakad, R | 1 |
| Bailey, SR | 1 |
| Bryson, SW | 1 |
| Killen, JD | 1 |
| Cummins, S | 1 |
| Zhu, SH | 1 |
| Gamst, A | 1 |
| Kirby, C | 1 |
| Brandstein, K | 1 |
| Klonoff-Cohen, H | 1 |
| Chaplin, E | 1 |
| Morris, T | 1 |
| Seymann, G | 1 |
| Lee, J | 1 |
| Hruškovičová, H | 1 |
| Dušková, M | 1 |
| Simůnková, K | 1 |
| Hill, M | 1 |
| Pospíšilová, H | 1 |
| Rácz, B | 1 |
| Králíková, E | 1 |
| Vondra, K | 1 |
| Stárka, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Optimizing Tobacco Dependence Treatment in the Emergency Department[NCT02896400] | Phase 3 | 1,056 participants (Actual) | Interventional | 2017-02-13 | Completed | ||
| Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation[NCT00289653] | 23 participants (Actual) | Interventional | 2005-09-30 | Completed | |||
| En Pareja: A Latino Couples Intervention to Help Expectant Fathers Quit Smoking[NCT01040949] | 705 participants (Actual) | Interventional | 2008-09-30 | Completed | |||
| A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline[NCT01889771] | 1,495 participants (Actual) | Interventional | 2010-03-31 | Completed | |||
| The Effect of a Perioperative Smoking Cessation Program on Rates of Smoking Cessation/Reduction and Perioperative Complications: a Randomized Clinical Trial.[NCT01260233] | 168 participants (Actual) | Interventional | 2010-10-31 | Completed | |||
| Coordinating Smoking Cessation Treatment With Menstrual Cycle Phase to Improve Quit Outcomes: A Randomized Controlled Trial[NCT05515354] | Phase 4 | 1,200 participants (Anticipated) | Interventional | 2022-11-30 | Recruiting | ||
| Menstrual Cycle Effects on Smoking Cessation and Cue Reactivity[NCT00664755] | Phase 2 | 140 participants (Actual) | Interventional | 2007-07-31 | Completed | ||
| Distribution of Voucher vs. Direct Mailing of Nicotine Patches to Quitline Smokers[NCT01736085] | Phase 3 | 3,706 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| Does Dose Adjustment of Nicotine Replacement Therapies According to Saliva Cotinine Increase Efficacy of These Treatments of Assistance To the Nicotinic Weaning Of the High-Risk Patients?[NCT00235313] | Phase 4 | 300 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
| Effectiveness of a Stepped Primary Care Smoking Cessation Intervention Based on an Evidence Based Clinical Practice Guideline (ISTAPS Project)[NCT00125905] | 3,012 participants | Interventional | 2003-10-31 | Active, not recruiting | |||
| Smoking Cessation in Hospitalized Smokers[NCT01289275] | Phase 4 | 1,270 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Abstinence self reported and verified by exhaled carbon monoxide (NCT02896400)
Timeframe: 3 months
| Intervention | Participants (Count of Participants) |
|---|---|
| Brief Negotiated Interview (BNI) | 71 |
| Brief Negotiated Interview (BNI) CONTROL | 49 |
| Nicotine Replacement Therapy (NRT) | 76 |
| Nicotine Replacement Therapy (NRT) CONTROL | 44 |
| Quitline (QL) | 66 |
| Quitline (QL) CONTROL | 54 |
| Text | 61 |
| Text CONTROL | 59 |
Expired Co levels were measured to confirm smoking status (NCT00289653)
Timeframe: measured at week 10
| Intervention | parts per million (Mean) |
|---|---|
| Enrolled Participants | 9.2 |
self reported # cigarettes per day (NCT00289653)
Timeframe: Week 10
| Intervention | cigarettes per day (Mean) |
|---|---|
| Enrolled Participants | 3.7 |
Carbon monoxide (≤10 parts per million) verified abstinence during the last two weeks of treatment (NCT00664755)
Timeframe: 2 weeks
| Intervention | Participants (Count of Participants) |
|---|---|
| Varenicline | 25 |
| Transdermal Nicotine Patch | 13 |
At seven months post enrollment we will conduct a brief telephone survey to assess smoking status. The information obtained will allow us to determine six month prolonged abstinence rates. (NCT01736085)
Timeframe: Seven months post enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Usual Care | 61 |
| Voucher | 76 |
| Patches | 151 |
At the follow up evaluation, subjects will be asked if they have made a quit attempt that lasted at least 24 hours. (NCT01736085)
Timeframe: Two months post enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Usual Care | 455 |
| Voucher | 533 |
| Patches | 879 |
All participants will receive an assessment Interview 2-months after their initial contact with the Helpline. The interview will cover, as appropriate, tobacco use, use of quitting aids, pattern of quitting (including slips and relapse situations), and satisfaction with the services. The interview will be conducted over the telephone. (NCT01289275)
Timeframe: 2-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 19.6 |
| Nicotine Patches | 22.5 |
| Telephone Counseling + Patches | 24.0 |
| Brief Hospital Counseling | 18.4 |
All participants will receive an assessment Interview 6-months after their initial contact with the Helpline. The interview will cover, as appropriate, tobacco use, use of quitting aids, pattern of quitting (including slips and relapse situations), and satisfaction with the services. The interview will be conducted over the telephone. Intention to treat analysis. (NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 18.0 |
| Nicotine Patches | 23.4 |
| Telephone Counseling and Nicotine Patches | 22.1 |
| Brief Hospital Counseling | 18.7 |
(NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | percentage of participants (Number) |
|---|---|
| Telephone Counseling | 70.0 |
| Nicotine Patches | 78.9 |
| Telephone Counseling + Patches | 77.6 |
| Brief Hospital Counseling | 69.7 |
(NCT01289275)
Timeframe: 6-months post enrollment
| Intervention | Participants (Count of Participants) |
|---|---|
| Telephone Counseling | 45 |
| Nicotine Patches | 50 |
| Telephone Counseling + Patches | 53 |
| Brief Hospital Counseling | 51 |
2 reviews available for oxybutynin and Smoking Cessation
| Article | Year |
|---|---|
Smoking cessation-recent advances.
Topics: Australia; Benzazepines; Bupropion; Cardiovascular Diseases; Dopamine Uptake Inhibitors; Drug Therap | 2010 |
Pharmacotherapeutic management of nicotine dependence in pregnancy.
Topics: Female; Humans; Pregnancy; Pregnancy Complications; Smoking; Smoking Cessation; Tobacco Use Disorder | 2011 |
17 trials available for oxybutynin and Smoking Cessation
| Article | Year |
|---|---|
A Pilot Study of a Standardized Smoking Cessation Intervention for Patients with Vascular Disease.
Topics: Aneurysm; Cardiovascular Agents; Cholinergic Agents; Connecticut; Endovascular Procedures; Female; H | 2019 |
Tobacco dependence treatment in the emergency department: A randomized trial using the Multiphase Optimization Strategy.
Topics: Adult; Cost-Benefit Analysis; Emergency Service, Hospital; Female; Hotlines; Humans; Male; Middle Ag | 2018 |
Efficacy of a couple-based randomized controlled trial to help Latino fathers quit smoking during pregnancy and postpartum: the Parejas trial.
Topics: Adult; Fathers; Female; Hispanic or Latino; Humans; Male; Pamphlets; Postpartum Period; Pregnancy; P | 2015 |
Randomised trial of two nicotine patch protocols distributed through a state quitline.
Topics: Administration, Cutaneous; Adolescent; Adult; Cost-Benefit Analysis; Drug Costs; Female; Government | 2016 |
Cost-Effectiveness of Nicotine Patches for Smoking Cessation in Pregnancy: A Placebo Randomized Controlled Trial (SNAP).
Topics: Adult; Behavior Therapy; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Health Promotion; H | 2015 |
Long-term quit rates after a perioperative smoking cessation randomized controlled trial.
Topics: Administration, Cutaneous; Adult; Counseling; Female; Health Behavior; Health Knowledge, Attitudes, | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; | 2015 |
Increasing progesterone levels are associated with smoking abstinence among free-cycling women smokers who receive brief pharmacotherapy.
Topics: Adolescent; Adult; Benzazepines; Estradiol; Female; Humans; Menstrual Cycle; Middle Aged; Nicotine; | 2015 |
Gender differences in a randomized controlled trial treating tobacco use among adolescents and young adults with mental health concerns.
Topics: Adolescent; Adolescent Health Services; Female; Gender Identity; Humans; Male; Mental Disorders; Men | 2015 |
Nicotine-patch therapy on mucocutaneous lesions of Behcet's disease: a case series.
Topics: Adult; Behcet Syndrome; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nicotine; R | 2010 |
Genetic variation in three candidate genes and nicotine dependence, withdrawal and smoking cessation in hospitalized patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Catechol O-Methyltransferase; Double-Blind Method; Femal | 2010 |
Cognitive conflict following appetitive versus negative cues and smoking cessation failure.
Topics: Adult; Appetitive Behavior; Cognition Disorders; Conflict, Psychological; Cues; Dose-Response Relati | 2011 |
Adjustment of nicotine replacement therapies according to saliva cotinine concentration: the ADONIS* trial-a randomized study in smokers with medical comorbidities.
Topics: Administration, Buccal; Cardiovascular Diseases; Comorbidity; Cotinine; Counseling; Diabetes Mellitu | 2011 |
Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: a double-blind, randomized, placebo-controlled study.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Emergency Service, Hospital; Female; Humans; Male; Mid | 2011 |
The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy.
Topics: Administration, Intranasal; Black People; Body Mass Index; Bupropion; Dopamine Uptake Inhibitors; Fe | 2011 |
Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Breath Tests; | 2011 |
Predicting successful 24-hr quit attempt in a smoking cessation intervention.
Topics: Adult; Behavior Therapy; Double-Blind Method; Female; Follow-Up Studies; Health Promotion; Humans; L | 2011 |
Nicotine patches and quitline counseling to help hospitalized smokers stay quit: study protocol for a randomized controlled trial.
Topics: Administration, Cutaneous; Aftercare; California; Cost-Benefit Analysis; Counseling; Drug Costs; Hos | 2012 |
11 other studies available for oxybutynin and Smoking Cessation
| Article | Year |
|---|---|
Electronic cigarettes for adults with tobacco dependence enrolled in a tobacco treatment program: A pilot study.
Topics: Adult; Counseling; Electronic Nicotine Delivery Systems; Female; Harm Reduction; Humans; Male; Middl | 2018 |
Escalating doses of transdermal nicotine in heavy smokers: effects on smoking behavior and craving.
Topics: Administration, Cutaneous; Adult; Affect; Behavior, Addictive; Biomarkers; Carbon Monoxide; Comorbid | 2013 |
Reasons for non-adherence to nicotine patch therapy during the first month of a quit attempt.
Topics: Adult; Aged; Drug Costs; Female; Health Services Accessibility; Humans; Male; Medication Adherence; | 2015 |
Nicotine and metabolites determination in human plasma by ultra performance liquid chromatography-tandem mass spectrometry: a simple approach for solving contamination problem and clinical application.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Biotransformation; Calibratio | 2015 |
Transdermal nortriptyline hydrocloride patch formulated within a chitosan matrix intended to be used for smoking cessation.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Chitosan; Female; Humans; Ion | 2011 |
Does the number of free nicotine patches given to smokers calling a quitline influence quit rates: results from a quasi-experimental study.
Topics: Adult; Black People; Female; Follow-Up Studies; Hispanic or Latino; Hotlines; Humans; Male; Middle A | 2010 |
Associations between weight change over 8 years and baseline body mass index in a cohort of continuing and quitting smokers.
Topics: Adult; Aged; Body Mass Index; England; Family Practice; Female; Humans; Male; Middle Aged; Nicotine; | 2011 |
Use of nicotine replacement therapy for smoking reduction and during enforced temporary abstinence: a national survey of English smokers.
Topics: Adult; Age Factors; Chewing Gum; England; Female; Harm Reduction; Health Knowledge, Attitudes, Pract | 2011 |
Early effects of smoking cessation and weight gain on plasma adiponectin levels and insulin resistance.
Topics: Adiponectin; Adult; Aged; Carotid Arteries; Follow-Up Studies; Homeostasis; Humans; Insulin Resistan | 2011 |
Smoking cessation interventions: a primer for physicians: Comment on "Use of varenicline for 4 weeks before quitting smoking".
Topics: Benzazepines; Bupropion; Chewing Gum; Counseling; Delayed-Action Preparations; Drug Administration S | 2011 |
Effects of smoking cessation on hormonal levels in men.
Topics: Administration, Cutaneous; Adult; Analysis of Variance; Biomarkers; Body Mass Index; Dehydroepiandro | 2013 |